FRFranceEarnings
Sanofi third-quarter 2026 results
Sanofi management reviews Q3 results in a live audio webcast with the financial community, followed by Q&A. Dupixent growth and the immunology pipeline are the numbers that set the French pharma narrative.
- News
- 3/5
- Markets
- 3/5
- Overall
- 3/5

